# A Study of Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Lap. Prostatectomy

> **NCT01661166** · PHASE4 · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 3 (actual)

## Conditions studied

- Prostate Adenocarcinoma

## Interventions

- **DRUG:** Fesoterodine
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT01661166
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-04-15
- **Final completion:** 2013-04-15
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2020-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01661166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01661166, "A Study of Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Lap. Prostatectomy". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT01661166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*